Symbols / PETV $0.75 -6.13% PetVivo Holdings, Inc.

Healthcare • Medical Devices • United States • OQX
PETV Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. John Lai
Exch · Country OQX · United States
Market Cap 27.35M
Enterprise Value 26.17M
Income -10.21M
Sales 1.11M
FCF (ttm) -3.46M
Book/sh 0.10
Cash/sh 0.01
Employees 24
Insider 10d —
IPO Sep 08, 2014
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -1.00
PEG —
P/S 24.60
P/B 7.65
P/C —
EV/EBITDA -3.39
EV/Sales 23.54
Quick Ratio 0.41
Current Ratio 1.40
Debt/Eq 2.09
LT Debt/Eq —
EPS (ttm) -0.38
EPS next Y -0.75
EPS Growth —
Revenue Growth -51.00%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-02-17
Earnings (prior) 2026-02-17
ROA -136.56%
ROE -7.40%
ROIC —
Gross Margin 66.05%
Oper. Margin -7.66%
Profit Margin 0.00%
Shs Outstand 36.46M
Shs Float 26.86M
Insider Own 50.28%
Instit Own 0.00%
Short Float 1.00%
Short Ratio 4.45
Short Interest 129.10K
52W High 1.69
vs 52W High -55.62%
52W Low 0.60
vs 52W Low 25.00%
Beta 1.28
Impl. Vol. —
Rel Volume 1.31
Avg Volume 7.72K
Volume 10.14K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $0.80
Price $0.75
Change -6.13%
About

PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company's lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minnesota.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.75
Latest analyst target
3. DCF / Fair value
$-1.71
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.75
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2021-10-12 init ThinkEquity — → Buy $7
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-15 RUDELIUS ROBERT JAMES Director — 50,000 $0.40 $20,000
2026-03-23 A.L. SARROFF FUND, LLC Beneficial Owner of more than 10% of a Class of Security — 24,033 $0.68 $16,412
2026-03-13 A.L. SARROFF FUND, LLC Beneficial Owner of more than 10% of a Class of Security — 1,250,000 — —
2026-03-09 LOWENTHAL GARRY N Chief Financial Officer — 71,993 $0.69 $49,675
2026-03-09 COSTANTINO ROBERT J Director — 35,000 $0.74 $25,900
2026-03-09 LAI JOHN Chief Executive Officer — 72,282 $0.69 $49,875
2026-03-09 RUDELIUS ROBERT JAMES Director — 35,000 $0.74 $25,900
2026-03-09 JASPER JOSEPH WILLIAM Director — 35,000 $0.74 $25,900
2026-03-09 LEVITAN DIANE M Director — 15,000 $0.74 $11,100
2026-03-09 RUBEN JOSHUA DAVID Director — 53,832 $0.74 $39,836
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Total Revenue
1.13
+16.91%
0.97
+5.62%
0.92
+693.49%
0.12
Operating Revenue
1.13
+16.91%
0.97
+5.62%
0.92
+693.49%
0.12
Cost Of Revenue
0.14
+35.21%
0.10
-53.93%
0.22
+9.88%
0.20
Reconciled Cost Of Revenue
0.14
+35.21%
0.10
-53.93%
0.22
+9.88%
0.20
Gross Profit
0.99
+14.76%
0.87
+24.53%
0.70
+913.54%
-0.09
Operating Expense
9.05
-21.22%
11.49
+21.83%
9.43
+89.69%
4.97
Research And Development
1.58
+13.46%
1.40
+40.05%
1.00
+109.81%
0.47
Selling General And Administration
7.47
-26.01%
10.09
+19.68%
8.43
+87.57%
4.50
Selling And Marketing Expense
2.64
-22.22%
3.40
-0.31%
3.41
+153.07%
1.35
General And Administrative Expense
4.82
-27.94%
6.69
+33.25%
5.02
+59.53%
3.15
Other Gand A
4.82
-27.94%
6.69
+33.25%
5.02
+59.53%
3.15
Total Expenses
9.19
-20.72%
11.59
+20.10%
9.65
+86.59%
5.17
Operating Income
-8.06
+24.16%
-10.62
-21.62%
-8.73
-72.72%
-5.06
Total Operating Income As Reported
-8.06
+24.16%
-10.62
-21.62%
-8.73
-72.72%
-5.06
EBITDA
-7.69
+28.97%
-10.82
-25.56%
-8.62
-72.68%
-4.99
Normalized EBITDA
-7.65
+27.14%
-10.49
-21.76%
-8.62
-71.59%
-5.02
Reconciled Depreciation
0.35
+178.45%
0.13
+10.85%
0.11
+75.64%
0.07
EBIT
-8.04
+26.57%
-10.95
-25.37%
-8.73
-72.72%
-5.06
Total Unusual Items
-0.04
+87.65%
-0.33
0.00
-100.00%
0.03
Total Unusual Items Excluding Goodwill
-0.04
+87.65%
-0.33
0.00
-100.00%
0.03
Special Income Charges
0.07
+120.18%
-0.33
0.00
-100.00%
0.03
Other Special Charges
-0.07
-120.18%
0.33
—
-0.03
Net Income
-8.40
+23.33%
-10.96
-25.67%
-8.72
-73.83%
-5.01
Pretax Income
-8.40
+23.33%
-10.96
-25.67%
-8.72
-73.83%
-5.01
Net Non Operating Interest Income Expense
-0.36
-5461.01%
-0.01
-140.79%
0.02
+60.80%
0.01
Interest Expense Non Operating
0.36
+5461.01%
0.01
—
—
Net Interest Income
-0.36
-5461.01%
-0.01
-140.79%
0.02
+60.80%
0.01
Interest Expense
0.36
+5461.01%
0.01
—
—
Interest Income Non Operating
—
—
0.02
+60.80%
0.01
Interest Income
—
—
0.02
+60.80%
0.01
Other Income Expense
0.02
+104.87%
-0.33
—
0.03
Other Non Operating Income Expenses
0.06
-85.42%
0.39
—
—
Gain On Sale Of Security
-0.11
—
—
—
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-8.40
+23.33%
-10.96
-25.67%
-8.72
-73.83%
-5.01
Net Income From Continuing Operation Net Minority Interest
-8.40
+23.33%
-10.96
-25.67%
-8.72
-73.83%
-5.01
Net Income From Continuing And Discontinued Operation
-8.40
+23.33%
-10.96
-25.67%
-8.72
-73.83%
-5.01
Net Income Continuous Operations
-8.40
+23.33%
-10.96
-25.67%
-8.72
-73.83%
-5.01
Normalized Income
-8.36
+21.35%
-10.63
-21.91%
-8.72
-72.74%
-5.05
Net Income Common Stockholders
-8.40
+23.33%
-10.96
-25.67%
-8.72
-73.83%
-5.01
Diluted EPS
-0.41
+47.44%
-0.78
+8.24%
-0.85
-49.12%
-0.57
Basic EPS
-0.41
+47.44%
-0.78
+8.24%
-0.85
-49.12%
-0.57
Basic Average Shares
20.49
+46.68%
13.97
+36.65%
10.22
+16.69%
8.76
Diluted Average Shares
20.49
+46.68%
13.97
+36.65%
10.22
+16.69%
8.76
Diluted NI Availto Com Stockholders
-8.40
+23.33%
-10.96
-25.67%
-8.72
-73.83%
-5.01
Total Other Finance Cost
—
0.01
+140.79%
-0.02
-60.80%
-0.01
Line Item Trend 2024-03-31
Total Assets
3.12
Current Assets
1.04
Cash Cash Equivalents And Short Term Investments
0.09
Cash And Cash Equivalents
0.09
Other Short Term Investments
0.00
Receivables
0.02
Accounts Receivable
0.02
Other Receivables
—
Inventory
0.39
Raw Materials
0.33
Work In Process
0.02
Finished Goods
0.04
Prepaid Assets
0.54
Other Current Assets
0.01
Total Non Current Assets
2.07
Net PPE
2.02
Gross PPE
2.44
Accumulated Depreciation
-0.43
Properties
0.00
Buildings And Improvements
—
Machinery Furniture Equipment
0.14
Other Properties
1.88
Leases
0.42
Goodwill And Other Intangible Assets
0.03
Other Intangible Assets
0.03
Non Current Deferred Assets
—
Non Current Prepaid Assets
0.03
Total Liabilities Net Minority Interest
2.43
Current Liabilities
1.41
Payables And Accrued Expenses
1.06
Payables
0.82
Accounts Payable
0.82
Current Accrued Expenses
0.24
Total Tax Payable
—
Current Debt And Capital Lease Obligation
0.35
Current Debt
0.16
Other Current Borrowings
0.16
Current Capital Lease Obligation
0.19
Other Current Liabilities
—
Total Non Current Liabilities Net Minority Interest
1.02
Long Term Debt And Capital Lease Obligation
1.02
Long Term Debt
0.01
Long Term Capital Lease Obligation
1.00
Stockholders Equity
0.69
Common Stock Equity
0.69
Capital Stock
0.02
Common Stock
0.02
Preferred Stock
0.00
Share Issued
17.06
Ordinary Shares Number
17.06
Treasury Shares Number
0.00
Additional Paid In Capital
83.47
Retained Earnings
-82.80
Total Equity Gross Minority Interest
0.69
Total Capitalization
0.70
Working Capital
-0.37
Invested Capital
0.86
Total Debt
1.37
Net Debt
0.08
Capital Lease Obligations
1.19
Net Tangible Assets
0.66
Tangible Book Value
0.66
Current Notes Payable
—
Interest Payable
—
Inventories Adjustments Allowances
—
Other Equity Interest
—
Preferred Stock Equity
—
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Operating Cash Flow
-5.32
+28.27%
-7.42
-9.20%
-6.79
-62.74%
-4.17
Cash Flow From Continuing Operating Activities
-5.32
+28.27%
-7.42
-9.20%
-6.79
-62.74%
-4.17
Net Income From Continuing Operations
-8.40
+23.33%
-10.96
-25.67%
-8.72
-73.83%
-5.01
Depreciation Amortization Depletion
0.35
+178.45%
0.13
+10.85%
0.11
+75.64%
0.07
Depreciation
0.35
+178.45%
0.13
+21.24%
0.10
—
Amortization Cash Flow
—
0.01
-12.78%
0.01
—
Depreciation And Amortization
0.35
+178.45%
0.13
+10.85%
0.11
+75.64%
0.07
Amortization Of Intangibles
—
0.01
-12.78%
0.01
—
Other Non Cash Items
0.74
-14.30%
0.86
+70.09%
0.51
+66.87%
0.30
Stock Based Compensation
1.48
-33.46%
2.23
+52.13%
1.46
+108.11%
0.70
Operating Gains Losses
0.23
+51.90%
0.15
—
-0.03
Gain Loss On Investment Securities
0.29
—
—
—
Gain Loss On Sale Of PPE
0.00
0.00
—
—
Change In Working Capital
0.28
+61.86%
0.17
+206.16%
-0.16
+19.37%
-0.20
Change In Receivables
-0.04
-161.61%
0.07
+180.89%
-0.08
-3139.33%
-0.00
Changes In Account Receivables
-0.04
-161.61%
0.07
+180.89%
-0.08
-3139.33%
-0.00
Change In Inventory
0.07
+436.34%
-0.02
+92.72%
-0.27
-176.64%
-0.10
Change In Prepaid Assets
0.10
+133.37%
0.04
+163.01%
-0.07
+68.16%
-0.21
Change In Payables And Accrued Expense
0.34
+310.94%
0.08
-68.74%
0.26
+139.15%
0.11
Change In Accrued Expense
0.06
0.00
0.00
+100.00%
-0.04
Change In Payable
0.27
+232.91%
0.08
-68.74%
0.26
+80.04%
0.14
Change In Account Payable
0.27
+232.91%
0.08
-68.74%
0.26
+80.04%
0.14
Change In Other Current Liabilities
-0.18
0.00
—
—
Investing Cash Flow
-0.56
-82.28%
-0.31
+27.09%
-0.42
-131.43%
-0.18
Cash Flow From Continuing Investing Activities
-0.56
-82.28%
-0.31
+27.09%
-0.42
-131.43%
-0.18
Net PPE Purchase And Sale
-0.06
+79.48%
-0.31
+27.09%
-0.42
-175.23%
-0.15
Purchase Of PPE
-0.06
+79.48%
-0.31
+27.09%
-0.42
-175.23%
-0.15
Capital Expenditure
-0.56
-82.28%
-0.31
+27.09%
-0.42
-131.43%
-0.18
Net Intangibles Purchase And Sale
-0.50
0.00
0.00
+100.00%
-0.03
Purchase Of Intangibles
-0.50
0.00
0.00
+100.00%
-0.03
Financing Cash Flow
6.03
-17.92%
7.34
+362.59%
1.59
-84.80%
10.44
Cash Flow From Continuing Financing Activities
6.03
-17.92%
7.34
+362.59%
1.59
-84.80%
10.44
Net Issuance Payments Of Debt
2.16
+165.27%
0.81
+12810.45%
-0.01
+92.17%
-0.08
Issuance Of Debt
2.17
+164.02%
0.82
0.00
0.00
Repayment Of Debt
-0.01
-11.55%
-0.01
-4.05%
-0.01
+92.17%
-0.08
Long Term Debt Issuance
2.17
+164.02%
0.82
0.00
0.00
Long Term Debt Payments
-0.01
-11.55%
-0.01
-4.05%
-0.01
+92.17%
-0.08
Net Long Term Debt Issuance
2.16
+165.27%
0.81
+12810.45%
-0.01
+92.17%
-0.08
Net Common Stock Issuance
2.05
-68.59%
6.53
+327.54%
1.53
-85.03%
10.20
Proceeds From Stock Option Exercised
—
0.00
-100.00%
0.07
+58.35%
0.04
Net Other Financing Charges
—
—
—
0.28
Changes In Cash
0.14
+136.16%
-0.39
+93.11%
-5.63
-192.57%
6.08
Beginning Cash Position
0.09
-81.61%
0.48
-92.22%
6.11
+25800.53%
0.02
End Cash Position
0.23
+160.50%
0.09
-81.61%
0.48
-92.22%
6.11
Free Cash Flow
-5.89
+23.85%
-7.73
-7.07%
-7.22
-65.63%
-4.36
Interest Paid Supplemental Data
0.01
+431.47%
0.00
-44.65%
0.00
-70.52%
0.01
Income Tax Paid Supplemental Data
0.00
0.00
—
—
Change In Interest Payable
0.06
0.00
0.00
-100.00%
0.00
Common Stock Issuance
2.05
-68.59%
6.53
+327.54%
1.53
-85.03%
10.20
Issuance Of Capital Stock
3.87
-40.74%
6.53
+327.54%
1.53
-85.03%
10.20
Net Preferred Stock Issuance
1.82
0.00
—
—
Preferred Stock Issuance
1.82
0.00
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category